Prostate Cancer Screening Tests
Prostatefocus is a simple and easy genetic screening test to detect the presence of faulty DNA repair genes
Prostatefocus Genetic Screening Test
For men aged 40 and over
Test results in 7 working days
Identify predisposition risk
Prostatefocus is a simple and easy saliva sample genetic screening test to detect the presence of faulty DNA repair genes. It is used to identify men at high risk of developing aggressive life-threatening prostate cancer.
- For men aged 40+
- Your father or brother has had prostate cancer or there is a strong history of cancer in the family
- You are of African-Caribbean descent
Prostate Cancer is the most common cancer in the Dubai
Since the 1990s, UK prostate cancer rates have increased by 48% in males and are projected to rise to 60% by 2035.
Most men with early prostate cancer don’t have signs or symptoms which means the disease can progress and spread to a stage when curative treatment is not possible.
Prostate cancer is often non-aggressive, however 10-15% of men with prostate cancer develop aggressive life – threatening tumours at an early age which can be prone to spreading rapidly to an incurable stage.
A high proportion of men in the high-risk group carry faulty inherited cancer genes which affect cells’ ability to repair their DNA. Survival among men with faulty DNA repair genes is half that of men with no genetic mutations.
Family history is not enough — by testing everyone, you overlook no one.
Test for High-Risk Aggressive Prostate Cancer
The presence of faulty DNA repair genes enables identification of men at high risk of developing early aggressive life-threatening prostate cancer.
Patients identified with a high risk of prostate cancer can benefit from increased surveillance and preventative steps to better manage their disease.
Prostatefocus is a simple and easy genetic screening test to detect the presence of faulty DNA repair genes. It is used to identify men at high risk of developing aggressive life-threatening prostate cancer.
Patients who test positive with the Prostatefocus screening test can benefit from increased surveillance and preventative steps to better manage their risk for cancer.
If a pathogenic variant is identified, close relatives (children, siblings, parents) could have as high as a 50% risk of developing cancer.
Customer requests a pre-test consultation with a Healthcare Provider
Order Womanfocus directly from the Healthcare Provider
Collect saliva sample as per instructions.
CellDig receives the sample and performs the test.
Customer receives results via a follow up consultation with Healthcare Provider
Considering the Prostatefocus Genetic Screening Test?
The first step is to choose a Healthcare Provider from the nationwide specialist medical practices below and initiate contact with their expert counsellors. The Healthcare Provider counsellor will work with you to determine whether genetic testing is right for you and get you started on your personalised genetic testing journey.